CliniSciences

What CliniSciences does

CliniSciences is a privately held European distributor of reagents, instruments, and in vitro diagnostic (IVD) products serving immunology, cell biology, and molecular biology research. Headquartered in Nanterre, France with its legal entity CliniSciences LLC registered in Miramar Beach, Florida, the company operates across 15 countries through approximately 100 employees (the majority holding PhDs in science), serving more than 350,000 customers daily. Its catalog spans FPLC columns, histological dyes, plant culture products, cell study kits, culture flasks, immunoassays, IHC detection kits, lectins, NGS products, radiochemical products, tetramers and monomers, fluorescent gel stains (NeoDye DNA, GelRed, GelGreen, SYBR), and proprietary products including CellCover, the PA-3600 automated IHC staining system, the Oncogramme IVD for functional oncology testing, and the LymphoSign CE-IVD workflow for Non-Hodgkin Lymphoma subtyping.

The company generates revenue primarily through B2B e-commerce distribution at clinisciences.com, with product-specific unit pricing and zone-based shipping (e.g., USA $100 flat, European countries $39 with free shipping above approximately $520). Orders received before 16:00 are processed same day and shipped within two working days via express courier. CliniSciences supplements direct e-commerce with conference sponsorships (RBMP 2026, ICB CDT Chemical Biology 2026, Technician Partnership Conference 2026), an active webinar program, technical blog content, and email newsletters to drive demand within the scientific research community. The company has expanded its diagnostic capabilities through the 2024 acquisition of Oncomedics (Oncogramme IVD, with derogatory reimbursement from the French National Health Authority for colon cancer) and the acquisition of Genexpath (lymphoma and sarcoma IVD solutions), shifting the business mix incrementally toward proprietary clinical diagnostics alongside commodity reagent distribution. ISO 13485:2016 certification from IMQ underwrites the regulated product portfolio.

Name

CliniSciences

Legal name

CliniSciences LLC

Website

https://clinisciences.com

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

CliniSciences is a privately held French-European distributor of reagents, instruments, and in vitro diagnostic products for immunology, cell biology, molecular biology, and oncology research, serving over 350,000 customers across 15 countries with a PhD-staffed scientific support team.

Ownership category

akta.pro rank

Product category

Life Science Reagents and Instruments Distribution

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Autoimmune, Allergy & Specialized Immunology Diagnostics (HLAHAAAK)

Keywords

• Life science reagents
• Molecular biology instruments
• Immunology diagnostics
• Cell biology products
• In vitro diagnostics

Headquarters

HQ city

Nanterre

HQ country

France

HQ region

Europe

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Product Distribution (Reagents and Equipment): CliniSciences generates revenue by distributing reagents, instruments, and equipment for scientific research and medical diagnosis. Products span immunology, cellular biology, molecular biology, and in vitro diagnostics. The company sells across Europe and North America through its e-commerce platform and operates an ISO 13485:2016 certified quality management system.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

Core offering

CliniSciences distributes reagents, instruments, and in vitro diagnostic products for immunology, cellular biology, and molecular biology research. The catalog spans FPLC columns, histological dyes, plant culture products, cell study kits, culture flasks, immunoassays, IHC detection kits, lectins, NGS products, radiochemical products, tetramers and monomers, plus proprietary offerings such as Oncogramme, LymphoSign CE-IVD, CellCover, NeoDye DNA dyes, and the PA-3600 automated IHC staining system. The company also offers custom laboratory services including cell toxicity tests, immunoassays, culture growth, and antibody production.

Product overview

CliniSciences is a European distributor of reagents and instruments for immunology, cellular biology, and molecular biology research. The product portfolio spans multiple categories including NeoDye DNA fluorescent dyes for gel electrophoresis, CellCover for cell stabilization, and a comprehensive range of FPLC columns, immunoassays, IHC kits, NGS products, and research consumables. In the diagnostic space, CliniSciences offers the Oncogramme® in vitro diagnostic device for personalized cancer treatment, the LymphoSign CE-IVD workflow for lymphoma classification, and the PA-3600 automated IHC staining system. The company also provides custom laboratory services and has expanded through acquisitions including Oncomedics (Oncogramme®) and Genexpath (lymphoma and sarcoma diagnostics).

Differentiator

Problem solved

Functional benefit

Brands

• Oncomedics: A biotechnology company acquired by CliniSciences Group, specializing in personalized cancer treatments and in vitro diagnostic medical devices, particularly the Oncogramme® for determining tumor sensitivity to anti-tumoral agents
• Genexpath

Products and services

• NeoDye DNA Fluorescent Dyes A range of fluorescent dyes (NeoDye DNA Green, NeoDye DNA Red, NeoDye DNA Blue, NeoDye DNA Orange) for DNA visualization in agarose gel electrophoresis. Non-toxic alternative to ethidium bromide, compatible with standard molecular biology workflows and UV/blue light detection.
• CellCover Non-toxic, one-step stabilization reagent that protects DNA, RNA, and proteins simultaneously in human and animal cells, solid tissues, and cultured cells for several days without freezing. Cells maintain near in vivo morphology without chemical crosslinking, enabling direct RNA isolation and downstream applications including flow cytometry, NGS, and single-cell RNA sequencing.
• Oncogramme In vitro diagnostic medical device that provides oncologists with decision-making support to identify the most effective treatment combinations for cancer patients. Involves culturing patient tumor cells and analyzing their mortality in response to different therapeutic molecules. First targeted indication is colon cancer, with expansion planned to breast and ovarian cancer. Obtained derogatory reimbursement from the French National Health Authority.
• PA-3600 Automated IHC System Fully automated immunohistochemistry (IHC) staining system designed for anatomopathology and molecular diagnostics. Based on antigen-antibody specific binding with chromogenic reagents, enabling IHC, ISH, and FISH applications with precision, efficiency, and reproducibility.
• LymphoSign CE-IVD CE-IVD marked diagnostic workflow enabling classification of over 80 subtypes of Non-Hodgkin Lymphoma through RT-MLPSeq analysis of more than 130 genetic markers. 4-step workflow from RNA to result, compatible with FFPE samples and Illumina sequencers, supported by AI-based RT-MIS software referencing over 3,000 tumor profiles.
• CliniSciences Research Reagents and Instruments Catalog Comprehensive catalog of research reagents and instruments for immunology, cellular biology, and molecular biology, including FPLC columns, special histological dyes, plant culture products, cell study kits, culture flasks, immunoassays, IHC detection kits, lectins, NGS products, radiochemical products, and tetramers/monomers. Sold across Europe and North America through the e-commerce platform.
• CliniSciences Custom Laboratory Services Custom laboratory services for research and diagnostic applications, including cell toxicity tests, immunoassays, culture growth, and antibody production. Supports laboratories requiring bespoke assay development and execution.
• Genexpath Diagnostic Solutions In vitro diagnostic solutions for lymphomas and sarcomas. Acquired by CliniSciences Group to strengthen its leadership in molecular biology and hemato-oncology diagnostics.

Quantifiable outcome

• Supports over 350,000 customers daily through 100 employees in 15 countries
• +2 more outcomes

Named customers4 records

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

Six partnerships are on record, tiered core and minor.

• OncomedicscoreStrategic or Co-development PartnerCliniSciences acquired Oncomedics, a French biotechnology company specializing in the personalization of cancer treatments. Oncomedics developed the Oncogramme, an in vitro diagnostic medical device that provides oncologists with decision support to identify the most effective treatment combinations. First indication is colon cancer with expansion to breast and ovarian cancer. Oncomedics was founded in 2006 by Christophe Lautrette and Stephanie Giraud and has its own laboratory and production unit in Limoges, France. The company obtained derogatory reimbursement from the French National Health Authority for its Oncogramme test.
• GenexpathcoreStrategic or Co-development PartnerCliniSciences strengthened its leadership in molecular biology and hemato-oncology with the strategic acquisition of Genexpath, a specialist in in vitro diagnostic solutions for lymphomas and sarcomas. This acquisition reinforces CliniSciences' diagnostic portfolio in oncology.
• NEOSETACminorStrategic or Co-development PartnerNEOSETAC is a European networking project in which CliniSciences participates. Within NEOSETAC, CliniSciences works primarily in WP2 (Targeting of nanosystems), specifically in T2.1 (Antibody Selection) and T2.2 (Antibody Production). The focus is on training researchers in antibody production against breast cancer cell biomarkers and providing technical support for associating these antibodies with nanoparticles. REDINN, another company, visited CliniSciences as a NEOSETAC partner at the UAB Campus in Bellaterra.
• PSL AllianceminorGTM or Marketing PartnerCliniSciences joined the PSL Alliance, a dynamic global networking group for the IVD and RUO reagents industry, connecting with other industry players to strengthen its market presence.
• French Health Care AssociationminorGTM or Marketing PartnerCliniSciences joined the French Health Care Association as a member, providing a diversified and high-quality network to meet international markets with innovative French solutions.
• Angels SanteminorGTM or Marketing PartnerCliniSciences joined Angels Sante as Associate Corporate Member. Angels Sante is Europe's leading network of healthcare business angels, at the heart of healthcare start-ups, supporting CliniSciences' commitment to investing in scientific innovation.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Thermo Fisher Scientific: Global life-sciences distributor and manufacturer offering reagents, instruments, and diagnostics across immunology, cell biology, and molecular biology. Comparable as the dominant broad-line incumbent competing for the same research and IVD customers CliniSciences serves.
• Merck KGaA (MilliporeSigma Life Science): Supplies reagents, lab instruments, and diagnostic solutions through the Sigma-Aldrich and MilliporeSigma brands. Overlaps directly with CliniSciences' catalog across immunology, cell biology, and molecular biology, and competes for academic and pharma research accounts.
• Revvity (formerly PerkinElmer): Offers reagents, automated IHC/ISH systems, and diagnostics solutions across life sciences and applied markets. Comparable to CliniSciences in automated pathology (PA-3600) and oncology diagnostics.
• Eurofins Scientific: European-headquartered provider of laboratory testing services and life-science products across pharma, food, and clinical diagnostics. Overlaps with CliniSciences on European distribution reach and diagnostic service offerings.

Direct peers

• Bio-Techne: Develops and manufactures purified proteins, antibodies, immunoassays, and diagnostics reagents for life-science research and clinical diagnostics. Comparable as a specialty reagent and IVD player competing in similar research and oncology workflows.
• QIAGEN: Provides molecular biology reagents, sample-preparation technologies, and IVD assays including oncology and hematology diagnostics. Directly comparable to CliniSciences on the molecular biology / IVD axis, especially LymphoSign-type lymphoma workflows.
• Abcam: Specializes in antibody reagents and immunoassay tools for life-science research, including oncology and immunology. Competes with CliniSciences' immunoassays, IHC detection kits, and antibody offerings.
• BioLegend: Manufactures antibodies, immunoassays, and cell biology reagents for academic and clinical research. Comparable specialty reagent vendor competing for immunology and cell biology customers in CliniSciences' segment.
• Cell Signaling Technology: Specializes in antibodies and reagent kits for cell signaling, cancer research, and IHC applications. Comparable to CliniSciences in IHC detection kits and oncology research reagents.
• Santa Cruz Biotechnology: Supplies research antibodies, biochemicals, and lab reagents for life-science research including cancer and immunology applications. Comparable specialty reagent vendor competing in similar research reagent categories.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/CliniSciences
• LinkedInlinkedin.com/company/clinisciences

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CliniSciences